| Particulars |
|
|
|
| Company Name
| Gland Pharma Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
16.50 |
B.V. (₹) |
686.10 |
| Sales(₹ Cr.) |
4,552.09 |
NP (₹ Cr.) |
1,315.23 |
| NP Var% |
21.00 |
Div% |
2,000.00 |
| CPS(₹) |
90.40 |
EPS (₹) |
79.70 |
| Traded Value(₹ Lakhs) |
517.72 |
52 Week High |
3,209.00 |
| 52 Week Low |
1,575.00 |
Price BSE |
3,126.00 |
| Price NSE |
3,133.00 |
Market Capital (₹ Cr.) |
51,584.87 |
| P/C Ratio |
34.60 |
P/E Ratio |
39.20 |
| Price Vs.BV |
4.56 |
|
| Latest Quarter |
| Year End |
202609 |
Sales (₹ Cr.) |
1,401.90 |
| NP(₹ Cr.) |
424.88 |
NP Var % |
41.00 |
| Trailing Twelve Months |
| Year End |
202609 |
Sales |
4,347.71 |
| OPM |
34.13 |
NP |
1,102.85 |
| NP Var% |
32.78 |
EPS |
93.05 |
| PE |
33.60 |
|
|